Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Quick Stats
Jan 30, 202658.4
AI Score
HOLD2.1
Volume Ratio
Feb 24, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
NVCT Stock Summary
Last updated Jan 30, 2026
NVCT is currently trading at $8.11, positioned above its 200-day moving average of $7.5, indicating a long-term uptrend. The stock has a 52-week range of $5.55 to $11.52.
Technical Analysis: The 50-day moving average stands at $7.56, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 48.901, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.077, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates NVCT at 58.4/100 with a HOLD recommendation.
NVCT (Nuvectis Pharma, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 48.901 |
| CMF (20) | 0.077 |
| ROC (10) | -4.924 |
| ADX (14) | 35.935 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.217 |
| AROONOSC (14) | -42.857 |
| WILLAMS %R (14) | -82.828 |
| MFI (14) | 44.052 |
NVCT Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
NVCT Price vs Max Options Open Interest
NVCT Max Change In Options Open Interest
NVCT Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NVCT Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NVCT Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NVCT Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Nuvectis Pharma, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
NVCT Moving Averages Analysis
Nuvectis Pharma, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Nuvectis Pharma, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
NVCT (Nuvectis Pharma, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 8.51 |
| 20 | 8.49 |
| 30 | 8.24 |
| 50 | 7.56 |
| 100 | 6.85 |
| 200 | 7.5 |
NVCT Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 218.2 million |
| Earnings/Share ($) | -1.37 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.312 |
| EPS Estimate Next Year ($) | -1.1033 |
| WallStreet Target Price ($) | 18.1667 |
| Most Recent Quarter |